ITeos Therapeutics Inc (ITOS) USD0.001

Sell:$5.64Buy:$6.07$0.34 (5.70%)

Prices delayed by at least 15 minutes
Sell:$5.64
Buy:$6.07
Change:$0.34 (5.70%)
Prices delayed by at least 15 minutes
Sell:$5.64
Buy:$6.07
Change:$0.34 (5.70%)
Prices delayed by at least 15 minutes

Company Information

About this company

iTeos Therapeutics, Inc. is a clinical-stage biopharmaceutical company. The Company is focused on the discovery and development of a new generation of immuno-oncology therapeutics for people living with cancer. Its pipeline includes three clinical-stage programs targeting novel, validated immuno-oncology pathways. Its lead antibody product candidate, belrestotug, also known as EOS-448/GSK4428859A, is an antagonist of TIGIT, an immune checkpoint with multiple mechanisms of action. Its advanced program is inupadenant, also known as EOS-850, a next-generation adenosine 2A receptor (A2AR) antagonist tailored to overcome the specific adenosine-mediated immunosuppression found in the tumor microenvironment. Its program to initiate clinical trials is EOS-984, a potentially first-in-class small molecule focused on a new mechanism in the adenosine pathway by targeting equilibrative nucleoside transporter 1 (ENT1), a dominant transporter of adenosine on lymphocytes involved in T cell metabolism.

Key people

Michel Marcel Detheux
President, Chief Executive Officer, Director
Matthew Gall
Chief Financial Officer
Matthew Call
Chief Operating Officer
Yvonne Mcgrath
Chief Scientific Officer
David Feltquate
Chief Medical Officer
David L. Hallal
Non-Executive Independent Chairman of the Board
Jill Desimone
Independent Director
Tony W. Ho
Independent Director
Robert Iannone
Independent Director
David K. Lee
Independent Director
Click to see more

Key facts

  • EPIC
    ITOS
  • Location
    United States
  • Sector
    Healthcare
  • Industry
    Biotechnology & Drugs
  • ISIN
    US46565G1040
  • Market cap
    $241.39m
  • Employees
    173
  • Shares in issue
    38.19m
  • Exchange
    NASDAQ
  • Index
    TR Equity United States Index

Data policy - All information should be used for indicative purposes only. You should independently check data before making any investment decision. HL cannot guarantee that the data is accurate or complete, and accepts no responsibility for how it may be used. Overview data is sourced from Refinitiv.